BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Büsing KA, Schönberg SO, Brade J, Wasser K. Impact of blood glucose, diabetes, insulin, and obesity on standardized uptake values in tumors and healthy organs on 18F-FDG PET/CT. Nucl Med Biol 2013;40:206-13. [PMID: 23228852 DOI: 10.1016/j.nucmedbio.2012.10.014] [Cited by in Crossref: 57] [Cited by in F6Publishing: 54] [Article Influence: 5.7] [Reference Citation Analysis]
Number Citing Articles
1 Ruiz-Bedoya CA, Gordon O, Mota F, Abhishek S, Tucker EW, Ordonez AA, Jain SK. Molecular Imaging of Diabetic Foot Infections: New Tools for Old Questions. Int J Mol Sci 2019;20:E5984. [PMID: 31795077 DOI: 10.3390/ijms20235984] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
2 Gabriel E, Alnaji R, Du W, Attwood K, Kukar M, Hochwald S. Effectiveness of Repeat 18F-Fluorodeoxyglucose Positron Emission Tomography Computerized Tomography (PET-CT) Scan in Identifying Interval Metastases for Patients with Esophageal Cancer. Ann Surg Oncol 2017;24:1739-46. [PMID: 28058562 DOI: 10.1245/s10434-016-5754-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
3 Goncalves MD, Taylor S, Halpenny DF, Schwitzer E, Gandelman S, Jackson J, Lukose A, Plodkowski AJ, Tan KS, Dunphy M, Jones LW, Downey RJ. Imaging skeletal muscle volume, density, and FDG uptake before and after induction therapy for non-small cell lung cancer. Clin Radiol 2018;73:505.e1-8. [PMID: 29317048 DOI: 10.1016/j.crad.2017.12.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
4 Ozaki K, Harada K, Terayama N, Kosaka N, Kimura H, Gabata T. FDG-PET/CT imaging findings of hepatic tumors and tumor-like lesions based on molecular background. Jpn J Radiol 2020;38:697-718. [PMID: 32246350 DOI: 10.1007/s11604-020-00961-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Aragaki M, Kato T, Fujiwara-Kuroda A, Hida Y, Kaga K, Wakasa S. Preoperative identification of clinicopathological prognostic factors for relapse-free survival in clinical N1 non-small cell lung cancer: a retrospective single center-based study. J Cardiothorac Surg 2020;15:229. [PMID: 32859238 DOI: 10.1186/s13019-020-01272-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Nam HY, Jun S, Pak K, Kim IJ. Concurrent Low Brain and High Liver Uptake on FDG PET Are Associated with Cardiovascular Risk Factors. Korean J Radiol 2017;18:392-401. [PMID: 28246520 DOI: 10.3348/kjr.2017.18.2.392] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
7 Keramida G, Roldao Pereira L, Kaya G, Peters AM. Hepatic and splenic 18 F‐FDG blood clearance rates (Ki) in hepatic steatosis and diabetes mellitus. Clin Physiol Funct Imaging 2019;40:99-105. [DOI: 10.1111/cpf.12610] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 Jensen JK, Zobel EH, von Scholten BJ, Rotbain Curovic V, Hansen TW, Rossing P, Kjaer A, Ripa RS. Effect of 26 Weeks of Liraglutide Treatment on Coronary Artery Inflammation in Type 2 Diabetes Quantified by [64Cu]Cu-DOTATATE PET/CT: Results from the LIRAFLAME Trial. Front Endocrinol (Lausanne) 2021;12:790405. [PMID: 34917038 DOI: 10.3389/fendo.2021.790405] [Reference Citation Analysis]
9 Deshayes E, de Forges H, Fraisse J, Eberlé MC, Guillemard S, Fallières A, Pouget JP, Tétreau R, Kotzki PO, Santoro L, Senesse P, Flori N. Artificial nutrition in patients with cancer has no impact on tumour glucose metabolism: Results of the PETANC Study. Clin Nutr 2019;38:2121-6. [PMID: 30209026 DOI: 10.1016/j.clnu.2018.08.033] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
10 Agca R, Blanken AB, van Sijl AM, Smulders YM, Voskuyl AE, van der Laken C, Boellaard R, Nurmohamed MT. Arterial wall inflammation is increased in rheumatoid arthritis compared with osteoarthritis, as a marker of early atherosclerosis. Rheumatology (Oxford) 2021;60:3360-8. [PMID: 33447846 DOI: 10.1093/rheumatology/keaa789] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
11 Ozguven MA, Karacalioglu AO, Ince S, Emer MO. Altered biodistribution of FDG in patients with type-2 diabetes mellitus. Ann Nucl Med 2014;28:505-11. [DOI: 10.1007/s12149-014-0840-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
12 Zareian P, Mirzaii Dizgah I. Serum Interleukin 17 in Type 2 Diabetes Mellitus. J Arch Mil Med 2014;2. [DOI: 10.5812/jamm.24689] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
13 Omiya Y, Ichikawa S, Satoh Y, Motosugi U, Nakajima N, Onishi H. Prognostic value of preoperative fluorodeoxyglucose positron emission tomography/computed tomography in patients with potentially resectable pancreatic cancer. Abdom Radiol 2018;43:3381-9. [DOI: 10.1007/s00261-018-1647-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
14 Martis N, Viau P, Zenone T, Andry F, Grados A, Ebbo M, Castela E, Brihaye B, Denis E, Liguori S, Audemard A, Schoindre Y, Morin AS, Terrier B, Marcq L, Mounier N, Lidove O, Chaborel JP, Quinsat D. Clinical value of a [18F]-FDG PET-CT muscle-to-muscle SUV ratio for the diagnosis of active dermatomyositis. Eur Radiol 2019;29:6708-16. [PMID: 31250167 DOI: 10.1007/s00330-019-06302-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
15 Gross J, Palmowski K, Doleschel D, Rix A, Gremse F, Verburg F, Mottaghy FM, Kiessling F, Lederle W, Palmowski M. Change of Apoptosis and Glucose Metabolism in Lung Cancer Xenografts during Cytotoxic and Anti-Angiogenic Therapy Assessed by Annexin V Based Optical Imaging and 18F-FDG-PET/CT. Contrast Media Mol Imaging 2021;2021:6676337. [PMID: 34007252 DOI: 10.1155/2021/6676337] [Reference Citation Analysis]
16 Yao Y, Cheng J, Su M, Ou X. Effects of Fever on 18F-FDG Distribution In Vivo: a Preliminary Study. Mol Imaging Biol 2020;22:1116-23. [PMID: 32100227 DOI: 10.1007/s11307-020-01486-9] [Reference Citation Analysis]
17 Xiao J, Yu H, Sui X, Hu Y, Cao Y, Liu G, Zhang Y, Hu P, Wang Y, Li C, Xu B, Shi H. Can the BMI-based dose regimen be used to reduce injection activity and to obtain a constant image quality in oncological patients by 18F-FDG total-body PET/CT imaging? Eur J Nucl Med Mol Imaging 2021. [PMID: 34185138 DOI: 10.1007/s00259-021-05462-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Karvani M, Kapoukranidou D. Implementation of Imaging Methods in Evaluation of T2DM-Correlated Brain Alterations and Cognitive Dysfunction. Acta Inform Med 2020;28:138-43. [PMID: 32742067 DOI: 10.5455/aim.2020.28.138-143] [Reference Citation Analysis]
19 TeSlaa T, Bartman CR, Jankowski CSR, Zhang Z, Xu X, Xing X, Wang L, Lu W, Hui S, Rabinowitz JD. The Source of Glycolytic Intermediates in Mammalian Tissues. Cell Metab 2021;33:367-378.e5. [PMID: 33472024 DOI: 10.1016/j.cmet.2020.12.020] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 12.0] [Reference Citation Analysis]
20 Nakahara M, Ito M, Hattori N, Magota K, Takahata M, Nagahama K, Sudo H, Kamishima T, Tamaki N, Iwasaki N. 18F-FDG-PET/CT better localizes active spinal infection than MRI for successful minimally invasive surgery. Acta Radiol 2015;56:829-36. [PMID: 25080515 DOI: 10.1177/0284185114541983] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 3.1] [Reference Citation Analysis]
21 Nakajima R, Abe K, Sakai S. Diagnostic Ability of FDG-PET/CT in the Detection of Malignant Pleural Effusion. Medicine (Baltimore) 2015;94:e1010. [PMID: 26200610 DOI: 10.1097/MD.0000000000001010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
22 Martin J, Saleem N. 18F-FDG PET-CT scanning and diabetic patients: what to do? Nucl Med Commun 2014;35:1197-203. [PMID: 25211626 DOI: 10.1097/MNM.0000000000000197] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 Berger NA. Obesity and cancer pathogenesis. Ann N Y Acad Sci. 2014;1311:57-76. [PMID: 24725147 DOI: 10.1111/nyas.12416] [Cited by in Crossref: 113] [Cited by in F6Publishing: 105] [Article Influence: 14.1] [Reference Citation Analysis]
24 Yoshida K, Yokoh H, Toriihara A, Fujii H, Harata N, Isogai J, Tateishi U. 18F-FDG PET/CT imaging of atypical subacute thyroiditis in thyrotoxicosis: A case report. Medicine (Baltimore) 2017;96:e7535. [PMID: 28746199 DOI: 10.1097/MD.0000000000007535] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
25 Tan H, Sui X, Yin H, Yu H, Gu Y, Chen S, Hu P, Mao W, Shi H. Total-body PET/CT using half-dose FDG and compared with conventional PET/CT using full-dose FDG in lung cancer. Eur J Nucl Med Mol Imaging 2021;48:1966-75. [PMID: 33244618 DOI: 10.1007/s00259-020-05091-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
26 Keramida G, Dizdarevic S, Bush J, Peters AM. Quantification of tumour (18) F-FDG uptake: Normalise to blood glucose or scale to liver uptake? Eur Radiol 2015;25:2701-8. [PMID: 25899414 DOI: 10.1007/s00330-015-3659-6] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 3.9] [Reference Citation Analysis]
27 Altmayer S, Zanon M, Sprinz C, Watte G, Hochhegger B. Is the effect of hyperglycemia on liver 18F-FDG standardized uptake value really clinically significant? Eur J Nucl Med Mol Imaging 2019;46:1216-7. [PMID: 30806749 DOI: 10.1007/s00259-019-04288-6] [Reference Citation Analysis]
28 Asai S, Fukumoto T, Tanji N, Miura N, Miyagawa M, Nishimura K, Yanagihara Y, Shirato A, Miyauchi Y, Kikugawa T, Yokoyama M. Fluorodeoxyglucose positron emission tomography/computed tomography for diagnosis of upper urinary tract urothelial carcinoma. Int J Clin Oncol 2015;20:1042-7. [PMID: 25794920 DOI: 10.1007/s10147-015-0817-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
29 Wu YW, Tseng PH, Lee YC, Wang SY, Chiu HM, Tu CH, Wang HP, Lin JT, Wu MS, Yang WS. Association of esophageal inflammation, obesity and gastroesophageal reflux disease: from FDG PET/CT perspective. PLoS One 2014;9:e92001. [PMID: 24642729 DOI: 10.1371/journal.pone.0092001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
30 Cui Y, Jiao Y, Chen HJ, Ding J, Luo B, Peng CY, Ju SH, Teng GJ. Aberrant functional connectivity of default-mode network in type 2 diabetes patients. Eur Radiol 2015;25:3238-46. [PMID: 25903712 DOI: 10.1007/s00330-015-3746-8] [Cited by in Crossref: 60] [Cited by in F6Publishing: 59] [Article Influence: 8.6] [Reference Citation Analysis]
31 Finessi M, Bisi G, Deandreis D. Hyperglycemia and 18F-FDG PET/CT, issues and problem solving: a literature review. Acta Diabetol 2020;57:253-62. [PMID: 31304560 DOI: 10.1007/s00592-019-01385-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
32 Sarikaya I, Albatineh AN, Sarikayaa A. Effect of various blood glucose levels on regional FDG uptake in the brain. Asia Ocean J Nucl Med Biol 2020;8:46-53. [PMID: 32064282 DOI: 10.22038/aojnmb.2019.14418] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
33 Henriksen OM, Holm S, Marner L, Law I. Effect of blood glucose and body weight on image quality in brain [18F]FDG PET imaging. Nucl Med Commun 2020;41:1265-74. [PMID: 32858605 DOI: 10.1097/MNM.0000000000001281] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Povoski SP, Murrey DA, Hall NC. 18F-FDG-Directed Surgery and 18F-FDG-Directed Interventional Procedures. In: Herrmann K, Nieweg OE, Povoski SP, editors. Radioguided Surgery. Cham: Springer International Publishing; 2016. pp. 419-45. [DOI: 10.1007/978-3-319-26051-8_25] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
35 Viglianti BL, Wale DJ, Wong KK, Johnson TD, Ky C, Frey KA, Gross MD. Effects of Tumor Burden on Reference Tissue Standardized Uptake for PET Imaging: Modification of PERCIST Criteria. Radiology 2018;287:993-1002. [PMID: 29558296 DOI: 10.1148/radiol.2018171356] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
36 Akcam AT, Teke Z, Saritas AG, Ulku A, Guney IB, Rencuzogullari A. The efficacy of 18F-FDG PET/CT in the preoperative evaluation of pancreatic lesions. Ann Surg Treat Res 2020;98:184-9. [PMID: 32274366 DOI: 10.4174/astr.2020.98.4.184] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
37 Sommariva S, Caviglia G, Sambuceti G, Piana M. Mathematical Models for FDG Kinetics in Cancer: A Review. Metabolites 2021;11:519. [PMID: 34436460 DOI: 10.3390/metabo11080519] [Reference Citation Analysis]
38 Wang R, Fan Q, Tian R, Su M. Intrapatient repeatability of background 18F-FDG uptake on PET/CT. Quant Imaging Med Surg 2021;11:4172-80. [PMID: 34476197 DOI: 10.21037/qims-20-769] [Reference Citation Analysis]
39 Oliveira AL, Azevedo DC, Bredella MA, Stanley TL, Torriani M. Visceral and subcutaneous adipose tissue FDG uptake by PET/CT in metabolically healthy obese subjects. Obesity (Silver Spring) 2015;23:286-9. [PMID: 25522219 DOI: 10.1002/oby.20957] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 3.4] [Reference Citation Analysis]
40 Morris M, Saboury B, Chen W, Siegel EL, Dasgeb B. Finding the sweet spot for metformin in 18F-FDG-PET. Nuclear Medicine Communications 2017;38:875-80. [DOI: 10.1097/mnm.0000000000000728] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Kaiser A, Davenport MS, Frey KA, Greenspan B, Brown RKJ. Management of Diabetes Mellitus Before 18F-Fluorodeoxyglucose PET/CT: A Nationwide Patient-Centered Assessment of Approaches to Examination Preparation. J Am Coll Radiol 2019;16:804-9. [PMID: 30348616 DOI: 10.1016/j.jacr.2018.09.006] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
42 BenAri O, Efrati S, Sano M, Bendlin BB, Lin H, Liu X, Sela I, Almog G, Livny A, Sandler I, Ben-Haim S, Sagi R, LeRoith D, Schnaider Beeri M, Ravona-Springer R. A double-blind placebo-controlled clinical trial testing the effect of hyperbaric oxygen therapy on brain and cognitive outcomes of mildly cognitively impaired elderly with type 2 diabetes: Study design. Alzheimers Dement (N Y) 2020;6:e12008. [PMID: 32296731 DOI: 10.1002/trc2.12008] [Reference Citation Analysis]
43 Krammer J, Schnitzer A, Kaiser CG, Buesing KA, Sperk E, Brade J, Wasgindt S, Suetterlin M, Schoenberg SO, Sutton EJ. (18) F-FDG PET/CT for initial staging in breast cancer patients - Is there a relevant impact on treatment planning compared to conventional staging modalities? Eur Radiol. 2015;25:2460-2469. [PMID: 25680729 DOI: 10.1007/s00330-015-3630-6] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
44 Fort R, Ledochowski S, Friggeri A. PET-CT in Critically Ill Patients: Diagnosing the Unsuspected. Crit Care Med 2018;46:e166-9. [PMID: 29206764 DOI: 10.1097/CCM.0000000000002888] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
45 Nardo L, Rezzani R, Facchetti L, Favero G, Franco C, Abdelhafez YG, Badawi RD, Guindani M, Seo Y, Pampaloni M. Beneficial Effects of Melatonin on Apolipoprotein-E Knockout Mice by Morphological and 18F-FDG PET/CT Assessments. Int J Mol Sci 2020;21:E2920. [PMID: 32331251 DOI: 10.3390/ijms21082920] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
46 Lv G, Miao Y, Chen Y, Lu C, Wang X, Xie M, Qiu L, Lin J. Promising potential of a 18F-labelled small-molecular radiotracer to evaluate PD-L1 expression in tumors by PET imaging. Bioorg Chem 2021;115:105294. [PMID: 34426150 DOI: 10.1016/j.bioorg.2021.105294] [Reference Citation Analysis]
47 Hendriks AM, Brouwers AH, Giannopoulos P, Lefrandt JD, Timens W, Groen HJM, de Bock GH, Jalving M. 18F-FDG PET/CT Scans Can Identify Sub-Groups of NSCLC Patients with High Glucose Uptake in the Majority of Their Tumor Lesions. J Cancer 2021;12:562-70. [PMID: 33391452 DOI: 10.7150/jca.45899] [Reference Citation Analysis]
48 Zhao Q, Zhou J, Pan Y, Ju H, Zhu L, Liu Y, Zhang Y. The difference between steroid diabetes mellitus and type 2 diabetes mellitus: a whole-body 18F-FDG PET/CT study. Acta Diabetol 2020;57:1383-93. [PMID: 32647998 DOI: 10.1007/s00592-020-01566-w] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
49 Sarikaya I, Sarikaya A, Sharma P. Assessing the Effect of Various Blood Glucose Levels on 18F-FDG Activity in the Brain, Liver, and Blood Pool. J Nucl Med Technol 2019;47:313-8. [PMID: 31182660 DOI: 10.2967/jnmt.119.226969] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
50 Sprinz C, Zanon M, Altmayer S, Watte G, Irion K, Marchiori E, Hochhegger B. Effects of blood glucose level on 18F fluorodeoxyglucose (18F-FDG) uptake for PET/CT in normal organs: an analysis on 5623 patients. Sci Rep 2018;8:2126. [PMID: 29391555 DOI: 10.1038/s41598-018-20529-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
51 Mahmud MH, Nordin AJ, Ahmad Saad FF, Azman AZ. Impacts of biological and procedural factors on semiquantification uptake value of liver in fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography imaging. Quant Imaging Med Surg 2015;5:700-7. [PMID: 26682140 DOI: 10.3978/j.issn.2223-4292.2015.05.02] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
52 Walczak R, Kawalilak L, Griffin L. Fluorine-18 fluorodeoxyglucose positron emission tomography-computed tomography for staging of canine insulinoma: 3 cases (2019-2020). J Small Anim Pract 2021. [PMID: 34811734 DOI: 10.1111/jsap.13446] [Reference Citation Analysis]
53 Takahashi Y, Suzuki S, Matsutani N, Kawamura M. 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the evaluation of clinically node-negative non-small cell lung cancer. Thorac Cancer 2019;10:413-20. [PMID: 30666803 DOI: 10.1111/1759-7714.12978] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
54 Sprinz C, Altmayer S, Zanon M, Watte G, Irion K, Marchiori E, Hochhegger B. Effects of blood glucose level on 18F-FDG uptake for PET/CT in normal organs: A systematic review. PLoS One 2018;13:e0193140. [PMID: 29486008 DOI: 10.1371/journal.pone.0193140] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 6.3] [Reference Citation Analysis]
55 Bang JI, Moon CM, Kim HO, Kang SY, Yoon HJ, Kim BS. Blood pool activity on F-18 FDG PET/CT as a possible imaging biomarker of metabolic syndrome. Sci Rep 2020;10:17367. [PMID: 33060688 DOI: 10.1038/s41598-020-74443-9] [Reference Citation Analysis]
56 Cuenoud B, Hartweg M, Godin JP, Croteau E, Maltais M, Castellano CA, Carpentier AC, Cunnane SC. Metabolism of Exogenous D-Beta-Hydroxybutyrate, an Energy Substrate Avidly Consumed by the Heart and Kidney. Front Nutr 2020;7:13. [PMID: 32140471 DOI: 10.3389/fnut.2020.00013] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
57 Silman C, Matsumoto S, Ono A, Kiyonaga M, Otsuka K. 18F-FDG uptake in the normal appendix in adults: PET/CT evaluation. Ann Nucl Med 2019;33:265-8. [PMID: 30652242 DOI: 10.1007/s12149-019-01330-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
58 Yuan H, Tong DK, Vardhanabhuti V, Khong PL. Factors that affect PERCIST-defined test-retest comparability: an exploration of feasibility in routine clinical practice. Clin Nucl Med 2015;40:941-4. [PMID: 26222536 DOI: 10.1097/RLU.0000000000000943] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]